Добавить новость
ru24.net
News in English
Февраль
2025
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
21
22
23
24
25
26
27
28

Axsome: Q4 Earnings Snapshot

0

NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Tuesday reported a loss of $74.9 million in its fourth quarter.

The New York-based company said it had a loss of $1.54 per share. Losses, adjusted for non-recurring costs, were 96 cents per share.

The results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1 per share.

The biopharmaceutical company posted revenue of $118.8 million in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $117.9 million.

For the year, the company reported that its loss widened to $287.2 million, or $5.99 per share. Revenue was reported as $385.7 million.

Axsome shares have risen 55% since the beginning of the year. The stock has climbed 40% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXSM at https://www.zacks.com/ap/AXSM

Source




Moscow.media
Частные объявления сегодня





Rss.plus




Спорт в России и мире

Новости спорта


Новости тенниса
ATP

Рублёв обыграл де Минора на тай-брейке и вышел в полуфинал турнира ATP в Дохе






"Сюжеты торжества тюрок над русскими": Мухетдинов опять угодил в скандал - в ДУМ РФ новая картина

Москва и Китайский центр трансфера технологий государств — членов ШОС обсудили возможности сотрудничества в области промышленности

Губернатор Воробьев обсудил с главой Электростали Волковой развитие округа

ПРОСВЕТИТЕЛЬСКИЙ МАРАФОН LG «НАСТАВНИЧЕСТВО. СОЗДАВАЯ БУДУЩЕЕ КОММУНИКАЦИЙ» ПОЛУЧИЛ ПРЕМИЮ DIGITAL COMMUNICATIONS AWARDS – 2025